$5.48
-0.14-2.49%
al cierre: -
$5.45
-0.03-0.55%
After hour: Aug 29, 6:29 PM EDT
Comments
Loading...
Solid Biosciences Actividad de operaciones con información privilegiada
SLDBNASDAQ
Actividad de operaciones de insiders
Sigue la actividad de operaciones con información privilegiada más reciente de Solid Biosciences. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de Solid Biosciences.
¿Qué es la actividad interna?
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
¿Qué están haciendo Solid Biosciences Inc los iniciados?
Los expertos no han informado de compras ni ventas en los últimos 30 días.
Compras y ventas recientes notables de información privilegiada
No ha habido ninguna compra o venta de información privilegiada en los últimos 90 días.
Estadísticas de propiedad de Solid Biosciences Inc
Acciones en circulación
77.869M
Acciones en manos de personas con información privilegiada
8.214M
Porcentaje de acciones en manos de personas con información privilegiada
10.6%
Acciones en manos de instituciones
16.267M
Porcentaje de acciones en manos de instituciones
21.0%
Mar 13, 2025 | — | 1.86K | $5.34 | $9.92K | BUY | 169.09% | 2.96K | Mar 11 | ||
Feb 21, 2025 | Bain Capital Life Sciences Investors LLCBCLS SB Investco LPBain Capital Life Sciences Partners LPBain Capital Life Sciences Fund II LPBain Capital Life Sciences Investors II LLCBCLS II Investco LPBCLS II Investco GP LLCBCIP Life Sciences Associates LPBCLS II Equity Opportunities LPBCLS II Equity Opportunities GP LLC | — | 1.00M | $4.03 | $4.03M | BUY | 24.79% | 5.03M | Feb 19 | |
Feb 21, 2025 | DIRECTOR | 5.00M | $4.03 | $20.15M | BUY | 72.39% | 11.91M | Feb 19 | ||
Feb 19, 2025 | 10% OWNER | 252.54K | $7.56 | $1.91M | BUY | 6.32% | 4.25M | Feb 18 | ||
Feb 18, 2025 | CHIEF REGULATORY OFFICER | 5.05K | $3.96 | -$12.19K | SELL-OPTIONS | 35.45% | 19.28K | Feb 13 - Feb 14 | ||
Feb 18, 2025 | CHIEF MEDICAL OFFICER | 7.68K | $3.96 | -$12.89K | SELL-OPTIONS | 50.76% | 22.81K | Feb 13 - Feb 14 | ||
Feb 18, 2025 | CFO & TREASURER | 7.46K | $3.96 | -$12.53K | SELL-OPTIONS | 30.10% | 32.25K | Feb 13 - Feb 14 | ||
Feb 18, 2025 | CHIEF OPERATING OFFICER | 9.13K | $3.96 | -$22.02K | SELL-OPTIONS | 58.26% | 24.79K | Feb 13 - Feb 14 | ||
Feb 18, 2025 | CHIEF TECHNOLOGY OFFICER | 4.50K | $3.96 | -$10.64K | SELL-OPTIONS | 32.39% | 18.39K | Feb 13 - Feb 14 | ||
Feb 18, 2025 | PRESIDENT AND CEO | 18.67K | $3.96 | -$45.01K | SELL-OPTIONS | 44.39% | 60.72K | Feb 13 - Feb 14 | ||
Feb 18, 2025 | — | 3.15K | $3.96 | -$6.78K | SELL-OPTIONS | 10.13% | 34.23K | Feb 13 - Feb 14 | ||
Jan 29, 2025 | — | 4.13K | $3.11 | -$447.78 | SELL-OPTIONS | 3.62% | 118.08K | Jan 27 - Jan 28 | ||
Jan 13, 2025 | CFO & TREASURER | 7.18K | $3.89 | -$15.85K | SELL-OPTIONS | 40.75% | 24.79K | Jan 09 - Jan 10 | ||
Jan 07, 2025 | — | 1.94K | $4.31 | -$4.55K | SELL-OPTIONS | 6.71% | 30.84K | Jan 03 - Jan 06 | ||
Dec 04, 2024 | CHIEF REGULATORY OFFICER | 7.25K | $5.60 | -$25.82K | SELL-OPTIONS | 103.85% | 14.23K | Dec 02 - Dec 03 | ||
Dec 04, 2024 | PRESIDENT AND CEO | 17.50K | $5.60 | -$62.24K | SELL-OPTIONS | 83.38% | 38.48K | Dec 02 - Dec 03 | ||
Dec 04, 2024 | CHIEF OPERATING OFFICER | 7.98K | $5.60 | -$28.40K | SELL-OPTIONS | 103.84% | 15.66K | Dec 02 - Dec 03 | ||
Dec 04, 2024 | CHIEF TECHNOLOGY OFFICER | 4.46K | $5.60 | -$15.55K | SELL-OPTIONS | 57.80% | 12.18K | Dec 02 - Dec 03 | ||
Oct 22, 2024 | CHIEF MEDICAL OFFICER | 6.83K | $6.50 | -$19.00K | SELL-OPTIONS | 164.43% | 10.98K | Oct 18 - Oct 21 | ||
Jun 11, 2024 | — | 1.10K | $7.67 | $8.44K | BUY | ∞ | 1.10K | Jun 07 | ||
May 06, 2024 | — | 1.09K | $10.33 | -$4.77K | SELL-OPTIONS | 3.92% | 28.90K | May 02 | ||
Jan 30, 2024 | — | 4.13K | $7.99 | -$1.11K | SELL-OPTIONS | 3.75% | 114.20K | Jan 27 - Jan 29 | ||
Jan 12, 2024 | DIRECTOR | 3.41M | $5.53 | $18.86M | BUY | 97.56% | 6.91M | Jan 11 | ||
Jan 12, 2024 | DIRECTOR | 904.16K | $5.53 | $5.00M | BUY | 26.61% | 4.30M | Jan 11 | ||
Jan 11, 2024 | CFO & TREASURER | 7.32K | $8.20 | -$32.27K | SELL-OPTIONS | 367.03% | 9.31K | Jan 09 | ||
Jan 05, 2024 | — | 1.85K | $5.30 | -$6.05K | SELL-OPTIONS | 7.20% | 27.56K | Jan 03 | ||
Dec 05, 2023 | PRESIDENT AND CEO | 16.86K | $2.77 | -$32.52K | SELL-OPTIONS | 2886.13% | 17.44K | Dec 02 - Dec 04 | ||
Dec 05, 2023 | CHIEF OPERATING OFFICER | 7.68K | $2.78 | -$14.92K | SELL-OPTIONS | ∞ | 7.68K | Dec 02 - Dec 04 | ||
Dec 05, 2023 | CHIEF TECHNOLOGY OFFICER | 4.27K | $2.77 | -$8.23K | SELL-OPTIONS | ∞ | 4.27K | Dec 02 - Dec 04 | ||
Dec 05, 2023 | CHIEF REGULATORY OFFICER | 6.98K | $2.78 | -$13.56K | SELL-OPTIONS | ∞ | 6.98K | Dec 02 - Dec 04 | ||
Dec 05, 2023 | CSO | 7.00K | $2.77 | -$13.52K | SELL-OPTIONS | ∞ | 7.00K | Dec 02 - Dec 04 | ||
Jun 08, 2023 | DIRECTOR | 2.65K | $4.85 | -$2.36K | SELL-OPTIONS | 2.53% | 107.15K | May 02 - Jun 02 | ||
Jan 31, 2023 | CHIEF SCIENTIFIC OFFICER | 792.00 | $7.49 | -$3.30K | SELL-OPTIONS | 4.18% | 19.76K | Jan 27 | ||
Jan 31, 2023 | DIRECTOR | 2.75K | $7.49 | -$11.41K | SELL-OPTIONS | 2.71% | 103.98K | Jan 27 | ||
Mar 15, 2022 | CHIEF SCIENTIFIC OFFICER | -22.66K | $1.10 | -$24.93K | SELL | -8.16% | 255.21K | Mar 14 | ||
Mar 15, 2022 | CHIEF OPERATING OFFICER | -30.50K | $1.10 | -$33.55K | SELL | -11.43% | 236.27K | Mar 14 | ||
Mar 08, 2022 | CEO & PRESIDENT | -463.00 | $1.12 | -$518.65 | SELL | -0.16% | 293.43K | Feb 10 | ||
Mar 23, 2021 | DIRECTOR | 2.61M | $5.75 | $15.00M | BUY | 24.15% | 13.41M | Mar 23 | ||
Mar 23, 2021 | DIRECTOR | 2.21M | $5.75 | $12.69M | BUY | 25.34% | 10.92M | Mar 19 | ||
Mar 15, 2021 | CHIEF SCIENTIFIC OFFICER | -23.40K | $8.84 | -$206.95K | SELL | -7.83% | 275.60K | Mar 12 | ||
Mar 15, 2021 | CHIEF OPERATING OFFICER | -23.40K | $8.84 | -$206.92K | SELL | -8.01% | 268.77K | Mar 12 | ||
Feb 16, 2021 | CEO & PRESIDENT | -457.00 | $7.66 | -$3.50K | SELL | -0.04% | 1.20M | Feb 12 | ||
Jan 29, 2021 | CFO, TREASURER & ASST. SECY | 8.03K | $6.14 | -$21.33K | SELL-OPTIONS | 2.45% | 335.64K | Jan 27 - Jan 28 | ||
Jan 29, 2021 | CHIEF TECHNOLOGY OFFICER | 8.06K | $6.14 | -$21.15K | SELL-OPTIONS | 2.84% | 292.17K | Jan 27 - Jan 28 | ||
Jan 29, 2021 | CHIEF SCIENTIFIC OFFICER | 8.04K | $6.14 | -$21.24K | SELL-OPTIONS | 2.76% | 299.00K | Jan 27 - Jan 28 | ||
Jan 29, 2021 | CEO & PRESIDENT | 24.79K | $6.14 | -$65.78K | SELL-OPTIONS | 2.10% | 1.20M | Jan 27 - Jan 28 |
PREGUNTAS FRECUENTES
¿Es legal el uso de información privilegiada?
Las operaciones con información privilegiada son legales siempre que se notifiquen a la Comisión de Bolsa y Valores (SEC). El comercio ilegal de valores se produce cuando la persona con información privilegiada viola un deber fiduciario o no informa de sus operaciones.
¿Cuáles son algunos ejemplos de manipulación del mercado?
Las operaciones con información privilegiada, los esquemas de pump and dump, el front running y las operaciones de lavado son ejemplos de manipulación del mercado. Los inversores que siguen el movimiento de activos con información privilegiada deben pensar atentamente por qué estos operadores con información privilegiada están negociando sus acciones antes de seguir adelante.
Explora operaciones con información privilegiada sobre todos los valores.